Main menu

Discover nanopore sequencing

What can it do?
How does it work?
Our platform performance and accuracy

Explore products

Prepare Library prep and automation solutions
Sequence Flow cells and nanopore devices
Analyse Software and informatics tools

Research

Microbial genomics
Plant
Human genomics
Animal
Cancer research
Microbiome
Infectious disease
Population genomics
Clinical research
Environmental research & conservation

Techniques

Whole-genome sequencing
Epigenetics
Transcriptomics
SNVs and phasing
Multiomics
Assembly
Metagenomics
Fusion transcripts
Targeted sequencing
Gene expression
Single cell & spatial transcriptomics
Splice variation
Structural variation
Chromatin conformation

Focus areas

From portable to high-throughput benchtop devices, real-time nanopore sensing is a new generation of technology uncovering new biology across multiple sectors.

Biopharma Education Clinical

Store Resources Support

Company

About us
Board members
Executive team
Investor centre
Company history
Sustainability
Careers
Media resources

News & Events

News
Events
Blogs

Global partners

Channel partners
Sequencing service providers
Compatible products
For partners

Search Oxford Nanopore Technologies

Which site do you wish to search in?

ont_prod_en_v3

Select options from the list below

All

All

www

www

Store

Store

Resources

Resources

0 result available.

Search Oxford Nanopore Technologies

Select options from the list below

0 result available.

Home

News

Search

427 results

Select options from the list below

Sort by : Most Relevant

Sort by : Newest

Sort by : Oldest

Sort by : Recent Activity

0 result available.

Company news
Healthcare leaders expect genomics to become part of routine care within a decade
September 30 2026
Company news
Oxford Nanopore joins global rare disease network RISE to expand access to genomic testing
September 29 2026
Company news
Oxford Nanopore technology supports NHS pilot of rapid genomic testing for brain tumours
September 25 2026
Company news
Oxford Nanopore further strengthens executive leadership team
August 25 2026
Company news
Francis Van Parys outlines our priorities for customers in Oxford Nanopore's next phase of growth
August 19 2026
Company news
Oxford Nanopore wins the 2026 MacRobert Award for engineering innovation
July 9 2026
Company news
VCGS achieves ISO 15189 accreditation for whole genome sequencing using Oxford Nanopore technology
July 7 2026
Company news
Action for ME announces research study for ME and Long Covid
May 12 2026
Company news
Cepheid and Oxford Nanopore expand partnership following successful phase one collaboration
April 15 2026
Company news
Oxford Nanopore and A.D.A.M. Innovations announce international collaboration to accelerate advanced genomic medicine in Japan
March 17 2026
Company news
ViruSure launches first GMP-validated viral safety test based on Oxford Nanopore sequencing
March 10 2026
Company news
Oxford Nanopore receives regulatory approval for its first diagnostic device in the UK and Europe
January 12 2026
Company news
Appointment of Francis Van Parys as Chief Executive Officer
December 8 2025
Company news
Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterise drug resistant-tuberculosis
November 5 2025
Company news
Oxford Nanopore announces PromethION Plus Flow Cell and other human genetics updates at ASHG 2025
October 15 2025
Company news
Bio-Techne and Oxford Nanopore expand agreement to accelerate development of genetics portfolio through 2032
October 9 2025
Company news
Oxford Nanopore launches a 24-hour whole genome sequencing workflow for rare disease research
September 30 2025
Company news
Oxford Nanopore launches Microbial Amplicon Barcoding Kit for faster, more flexible microbial profiling
September 18 2025
Company news
Oxford Nanopore launches a comprehensive Hereditary Cancer Panel
September 4 2025
Company news
ViruSure launches pioneering first-in-class viral contamination test for biopharmaceuticals using Oxford Nanopore technology
August 7 2025

Filter

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Modern slavery policy Accessibility

About Oxford Nanopore

Contact us News Media resources & contacts Investor centre Careers

© 2008 - 2026 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, AmPORE-TB, EPI2ME, GridION, MinION, MinKNOW, PromethION, P2 Solo, and P2 are registered trademarks or the subject of trademark applications of Oxford Nanopore Technologies plc in various countries. Information contained herein may be protected by copyright, patents or patents pending of Oxford Nanopore Technologies plc. All other brands and names contained are the property of their respective owners. Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in‐vitro diagnostic devices in some jurisdictions, please check individual product labelling.

Select Language

Select options from the list below

English

English

Español

Español

中文

中文

日本語

日本語

0 result available.